Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up    |  Already a member? Sign In
Pharma IQ

Regulatory/Legal

Ensure compliance with external submission standards. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in pharmaceutical regulatory affairs to exchange ideas on best practice and share case studies on innovation within the area.

Articles

How Can We Still Deliver an Effective Anti-Counterfeiting Program When Facing Cost Restraints?

Contributor: Pharma IQ
Posted: 1/27/2012

How Can We Still Deliver an Effective Anti-Counterfeiting Program When Facing Cost Restraints? - Pharma IQ

Cases of counterfeit pharmaceuticals being discovered entering the United States are on the up. Up 200 percent to $11 million (£7 million) in 2011 to be precise, based on the domestic value of seizures from the Customs and Border Protection (CBP) last year. Full Article »

Events related to this topic:
More Articles
Videos

Valea Video Series - Introduction to Valea

Contributor: Valea Content Series
Posted: 1/10/2012

Valea Video Series - Introduction to Valea - Valea Content Series

Meet a couple of Valea’s skilled and creative consultants and let them guide you through our offer, acomplete range of IP services. Valea’s team is made of consultants specialising in European patents, trademarks and design, as well as lawyers with specialist knowledge, considerable experience and expertise within all technical areasand legal issues related thereto. Our knowledge is combined with an in-depth understanding of the commercial value of intangible assets to our clients. Full Video »

Events related to this topic:
More Videos
Podcasts

Saudi FDA: Working with Industry to Improve the Reporting of Adverse Reactions

Contributor: Andrea Charles
Posted: 12/13/2011

Saudi FDA: Working with Industry to Improve the Reporting of Adverse Reactions - Andrea Charles

In this interview Dr. Nasser Al-Qahtani, Head, Adverse Drug Reactions Evaluation Department Saudi FDA, speaks to Pharma IQ, about the Saudi FDA pharmacovigilance system and what new guidelines he predicts will be areas for discussion amongst pharma/bio companies in 2012. Full Podcast »

Events related to this topic:
More Podcasts
Columns

Patent Drafting and Claim Construction

Contributor: Alpesh Pathak
Posted: 7/15/2011

Patent Drafting and Claim Construction - Alpesh Pathak

To determine whether the patentee has right to exclude for a particular claimed invention, it is essential to know what is claimed and this process is called determining the scope of the invention or claims construction. Full Column »

Events related to this topic:
More Columns
About Regulatory/Legal

This portal provides executives working within pharma and biotech regulatory affairs, with the latest regulations and their implications for the industry, IP strategies and solutions for successful patent litigation.


Advertisement

Events of Interest
Download Brochure

Please complete the information below to complete your download.

Please note: That all fields marked with an asterisk (*) are required.

First Name *
Last Name *
Job Title *
Company Name *
Email Address *
Telephone *
Country *
Where did you hear about us? *

I would like to receive information about sponsorship and exhibition opportunities

Yes, sign me up for the FREE Pharma IQ e-newsletter, including information on FREE Podcasts, Webinars, event discounts and online learning opportunities.

sir, we have a printing unit I want printing orders how to apply here

Posted by:  chikkegowda g | Answer this question

sir, we have a printing unit I want printing orders how to apply here

Posted by:  chikkegowda g | Answer this question

May I know the exact difference between DMF grade and non-DMF grade material?

Posted by:  sumankakimani1 | Answer this question

Hi What is the Job Profile of AREA BUSINESS MANAGER in PHARMA.

Posted by:  digvijay_singh24 | Answer this question

what is QA & QC Division In pharma .

Posted by:  amita25683 | Answer this question

How are GSK making leaps and strides in biopharma?

Posted by:  pharma_eye | Answer this question

Hi What is the Job Profile of AREA BUSINESS MANAGER in PHARMA.

Posted by:  digvijay_singh24 | Answer this question

What is a current topic of discussion in the pharmaceutical industry that could have an impact on pharmaceutical companies?

Posted by:  charlottebooth06@hotmail.co.uk | Answer this question